Abstract:Backgrounds The impaired function of endogenous bone marrow mesenchymal stem cells (BMSCs) is a determinant in the development of osteoporosis (OP). BMSCs have been described the potential relevance of autophagy to the pathogenesis of OP. However, the underlying mechanism remains unclear. Our previous researches have found leucine‐rich repeat‐containing 17 (LRRc17) secreted by MSCs, a member of the LRR superfamily, was markedly enriched in the age‐related pathways. This study aims to investigate the effects of LRRc17 in aging process of MSCs. Methods Hydrogen peroxide (H 2 O 2 ) induced aging MSCs and natural senescent cell cultivated from old and young C57BL/6 mice were used to evaluate the effects of LRRc17 on MSCs. Western blot, flow cytometry was used to detect autophagy, apoptosis and cell cycle respectively. Furthermore, mitochondrial function was measured by Mitosox, JC‐1, ATP. The mitochondrial morphology was detected by Mitotracker. Moreover, co‐culture was performed to detect the effects of LRRc17 secreted by MSCs on osteoblast (OB) and osteoclast (OC). Results MSCs exhibited a senescent phenotype after treatment with hydrogen peroxide. This result was improved after the addition of rapamycin. Interestingly, compared with the H 2 O 2 ‐treated group, MSCs transfected with shLRRc17 showed increased DNA synthesis phase, and decreased apoptosis ratio, ROS (Fig. 1A, B, C ). Autophagy related protein LC3 II, Beclin1 were up‐upregulated and P62 was down‐regulated (Fig. 1G ). And mitochondrial morphology was also significantly improved (Fig. 1D, E ). More importantly, LRRc17 reversed the loss of Ψm (Fig. 2A ) and enhanced ATP content (Fig. 1F ). Co‐culture showed that silenced LRRc17 in MSCs enhanced the osteogenic ability of OB and decreased the bone resorption capacity of OC, and the opposite result was obtained after overexpression (Fig. 2B ). Conclusions LRRc17 enhances characterizations of BMSCs through attenuating MSC senescence during OP, and which could lead to novel therapies to target altered bone formation. Support or Funding Information This work was supported by the Chengdu Giant Panda Breeding Research Foundation (2016cdspt001). Figure 1 Figure 2

Identification of A Small Molecule Preventing Bmsc Senescence in Vitro by Improving Intracellular Homeostasis Via Anxa7 and Hmbox1

Rejuvenation of BMSCs senescence by pharmacological enhancement of TFEB-mediated autophagy alleviates aged-related bone loss and extends lifespan in middle aged mice

Inhibition of annexin A7 suppresses senescence-associated heterochromatin foci formation and senescence through the AMPK/mTOR pathway in human dermal fibroblasts

Down-regulation of LRRc17 secreted by BMSCs alleviates age-related bone aging through autophagy enchancement

A Ph Probe Inhibits Senescence in Mesenchymal Stem Cells

Autophagy controls mesenchymal stem cell properties and senescence during bone aging

The Role of Box A of HMGB1 in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy

Senolytic Controls Bone Marrow Mesenchymal Stem Cells Fate Improving Bone Formation.

ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression

Indian Hedgehog regulates senescence in bone marrow-derived mesenchymal stem cell through modulation of ROS/mTOR/4EBP1, p70S6K1/2 pathway

ZIM1 Combined with Hydrogel Inhibits Senescence of Primary PαS Cells during In Vitro Expansion

Apoptotic Vesicles Rejuvenate Mesenchymal Stem Cells Via Rab7-mediated Autolysosome Formation and Alleviate Bone Loss in Aging Mice

miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway

Clock-modified Mesenchymal Stromal Cells Therapy Rescues Molecular Circadian Oscillation and Age-Related Bone Loss Via Mir142-3P/bmal1/yap Signaling Axis

Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation

Bmi-1 Epigenetically Orchestrates Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells to Delay Bone Aging

Marine derivative CHNQD-00603 reverses bone marrow mesenchymal stem cells senescence by enhancing autophagy through the AKT/ERK/mTOR signaling pathway

Regulating Mitochondrial Aging via Targeting the Gut‐Bone Axis in BMSCs With Oral Hydrogel Microspheres to Inhibit Bone Loss

Epigenetic therapy attenuates oxidative stress in BMSCs during ageing

Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice

Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells